Deng, Suqi
Du, Juan
Gale, Robert Peter
Wang, Lu
Zhan, Huien
Liu, Fangshu
Huang, Kexiu
Xu, Hao
Zeng, Hui http://orcid.org/0000-0002-4498-8888
Funding for this research was provided by:
National Natural Science Foundation of China (81970143, 82270167)
Guangdong Science and Technology Department (2021B1515020017)
Leading Talents Program from The First Affiliated Hospital of Jinan University to HZ. Municipal School Joint Program from Guangzhou Science and Technological Projec
DH | National Institute for Health Research
Article History
Received: 22 November 2022
Revised: 14 April 2023
Accepted: 19 April 2023
First Online: 29 April 2023
Competing interests
: RPG is a consultant to NexImmune Inc. Nanexa Pharma Ascentage Pharm Group and Antengene Biotech LLC, Medical Director of FFF Enterprises Inc.; Partner in AZCA Inc.; Board of Directors of Russian Foundation for Cancer Research Support and Scientific Advisory Board: StemRad Ltd.